#ZaiLab
Two drugs hoping to muscle in on Amgen's first-to-market DLL3-targeting drug Imdelltra – from #ZaiLab and #Ideaya – have new trial readouts at #ESMO26. #lungcancer

pharmaphorum.com/news/esmo26-...
October 24, 2026 at 12:09 PM
Zai Lab Files Form 13G on April 6, 2026: Zai Lab (NASDAQ: ZLAB) had a Form 13G filed on April 6, 2026, signaling a passive >5% disclosure under SEC Rule 13d-1 and a 45-day filing window for certain filers. 👈 Read full analysis #ZaiLab #Form13G #SEC #NASDAQ #Investment
Zai Lab Files Form 13G on April 6, 2026
Zai Lab (NASDAQ: ZLAB) had a Form 13G filed on April 6, 2026, signaling a passive >5% disclosure under SEC Rule 13d-1 and a 45-day filing window for certain filers.
dlvr.it
April 6, 2026 at 11:42 PM